Retraction Note: γ-Aminobutyric acid (GABA) administration improves action selection processes: a randomised controlled trial (Scientific Reports, (2015), 10.1038/srep12770);γ-Aminobutyric acid (GABA) administration improves action selection processes: A randomised controlled trial

Scientific Reports

Volumn 5, Issue , 2015, Pages 1-7

  Steenbergen, Laura ^a   Sellaro, Roberta ^a   Stock, Ann Kathrin ^b   Beste, Christian ^b   Colzato, Lorenza S ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID;

ADOLESCENT; AFFECT; BLOOD PRESSURE; CONTROLLED STUDY; DECISION MAKING; DRUG EFFECTS; EXECUTIVE FUNCTION; FEMALE; HEART RATE; HUMAN; MALE; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; AFFECT; BLOOD PRESSURE; DECISION MAKING; EXECUTIVE FUNCTION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 84938544014     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-022-13116-1     Document Type: Erratum

References (50)

1. Muckschel, M., Stock, A. K. & Beste, C. Psychophysiological mechanisms of interindividual differences in goal activation modes during action cascading. Cereb. Cortex 24, 2120-2129 (2014). doi: 10.1093/cercor/bht066.
2. Verbruggen, F., Schneider, D. W. & Logan, G. D. How to stop and change a response: the role of goal activation in multitasking. J. Exp. Psychol. Hum. 34, 1212-1228 (2008).
3. Stock, A. K., Arning, L., Epplen, J. T. & Beste, C. DRD1 and DRD2 Genotypes Modulate Processing Modes of Goal Activation Processes during Action Cascading. J. Neurosci. 34, 5335-5341 (2014).
4. Humphries, M. D., Stewart, R. D. & Gurney, K. N. A physiologically plausible model of action selection and oscillatory activity in the basal ganglia. J. Neurosci. 26, 12921-12942 (2006).
5. Bar-Gad, I., Morris, G. & Bergman, H. Information processing, dimensionality reduction and reinforcement learning in the basal ganglia. Prog. Neurobiol. 71, 439-473 (2003).
6. Redgrave, P., Prescott, T. J. & Gurney, K. The basal ganglia: A vertebrate solution to the selection problem? Neurosci. 89, 1009-1023 (1999).
7. Beste, C., Dziobek, I., Hielscher, H., Willemssen, R. & Falkenstein, M. Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease. Eur. J. Neurosci. 29, 855-860 (2009).
8. Beste, C. et al. Mechanisms mediating parallel action monitoring in fronto-striatal circuits. Neuroimage 62, 137-146 (2012).
9. Ravizza, S. M., Goudreau, J., Delgado, M. R. & Ruiz, S. Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation. Cogn. Affect. Behav. Neurosci. 12, 193-206 (2012).
10. Cameron, I. G., Watanabe, M., Pari, G. & Munoz, D. P. Executive impairment in Parkinson's disease: response automaticity and task switching. Neuropsychologia 48, 1948-1957 (2010).
11. Willemssen, R., Falkenstein, M., Schwarz, M., Muller, T. & Beste, C. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control. Neurobiol. Aging 32, 327-335 (2011).
12. Humphries, M. D. & Prescott, T. J. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog. Neurobiol. 90, 385-417 (2010).
13. Plenz, D. When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function. Trends Neurosci. 26, 436-443 (2003).
14. Adler, A., Finkes, I., Katabi, S., Prut, Y. & Bergman, H. Encoding by synchronization in the primate striatum. J. Neurosci. 33, 4854-4866 (2013).
15. Chase, T. N. & Taminga, C. A. GABA system participation in human motor, cognitive and endocrine function in GABANeurotransmitters. (eds Krogsgaard-Larson, P. et al.) 283-294 (Munksgaard, 1979).
16. Will, B. E., Toniolo, G. & Brailowsky, S. Unilateral infusion of GABA and saline into the nucleus basalis of rats: 1. Effects on motor function and brain morphology. Behav. Brain Res. 27, 123-129 (1988).
17. Boy F. et al. Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr. Biol. 20, 1779-1785 (2010).
18. Stagg, C. J., Bachtiar, V. & Johansen-Berg, H. The role of GABA in human motor learning. Curr. Biol. 21, 480-484 (2011).
19. Floyer-Lea, A., Wylezinska, M., Kincses, T. & Matthews, P. M. Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J. Neurophysiol. 95, 1639-1644 (2006).
20. Bari, A. & Robbins, T. W. Inhibition and impulsivity: behavioral and neural basis of response control. Prog. Neurobiol. 108, 44-79 (2013).
21. Quetscher, C. et al. Striatal GABA-MRS predicts response inhibition performance and its cortical electrophysiological correlates. Brain Struct. Funct. [Epub ahead of print] (2014). doi: 10.1007/s00429-014-0873-y
22. Yildiz, A. et al. Feeling safe in the plane: Neural mechanisms underlying superior action control in airplane pilot trainees - A combined EEG/MRS study. Hum. Brain Mapp. 35, 5040-5051 (2014).
23. Steenbergen, L. et al. Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during action cascading processes. Eur. Neuropsychopharmacol. [Epub ahead of print] (2015). doi: 10.1016/j.euroneuro.2015.03.015
24. Stock. A. K., Blaszkewicz, M. & Beste, C. Effects of binge drinking on action cascading processes: an EEG study. Arch. Toxicol. 88, 475-88 (2014).
25. Ticku, M. K. Alcohol and GABA-benzodiazepine receptor function. Ann. Med. 22, 241-246 (1990).
26. Haig, G. M. et al. Single-Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children. J. Clin. Pharmacol. 41, 507-514 (2001).
27. Rizzo, V. et al. Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation. Neuro. Sci. 22, 229-232 (2001).
28. Shyamaladevi, N., Jayakumar, A. R., Sujatha, R., Paul, V. & Subramanian, E. H. Evidence that nitric oxide production increases γ-amino butyric acid permeability of blood-brain barrier. Brain Res. Bull. 57, 231-236 (2002).
29. Knudsen, G. M., Poulsen, H. E. & Paulson, O. B. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport. J. Hepatol. 6, 187-192 (1988).
30. Bassett, M. L., Mullen, K. D., Scholz, B., Fenstermacher, J. D. & Jones, E. A. Increased brain uptake of gamma-amino butyric acid in a rabbit model of hepaticencephalopathy. Gastroenterol. 98, 747-757 (1990).
31. Errante, L. D., Williamson, A., Spencer, D. D. & Petroff, O. A. Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res. 49, 203-210 (2002).
32. Cai, K. et al. The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T 1H-MRS study. Neuropsychopharmacol. 37, 2764-2771 (2012).
33. Logan, G. D. & Cowan, W. B. On the ability to inhibit thought and action: A theory of an act of control. Psychol. Rev. 91, 295-327 (1984).
34. Logan G. D. On the ability to inhibit thought and action: A users' guide to the stop signal paradigm in Inhibitory Processes in Attention, Memory, and Language (eds Dagenbach, D. et al.) 189-239 (Academic Press, 1994).
35. Groenewegen, H. J. The basal ganglia and motor control. Neural Plast. 10, 107-120 (2003).
36. Draper, A. et al. Increased GABA contributes to enhanced control over motor excitability in tourette syndrome. Curr. Biol. 24, 2343-2347 (2014).
37. Streeter, C. C. et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J. Altern. Complement. Med. 16, 1145-1152 (2010).
38. Brambilla, P., Perez, J., Barale, F., Schettini, G. & Soares, J. C. GABAergic dysfunction in mood disorders. Mol. Psychiatry, 8, 721-737 (2003).
39. Schuch, S. & Koch, I. Mood states influence cognitive control: The case of conflict adaptation. Psychol. Res. [Epud ahead of print] (2014). doi: 10.1007/s00426-014-0602-4.
40. Van Steenbergen, H., Band, G. P. & Hommel, B. In the mood for adaptation how affect regulates conflict-driven control. Psychol. Sci. 21, 1629-1634 (2010).
41. Russell, J. A., Weiss, A. & Mendelsohn, G. A. Affect Grid: a single-item scale of pleasure and arousal. J. Pers. Soc. Psychol. 57, 493-502 (1989).
42. Zhang, W. & Mifflin, S. Plasticity of GABAergic mechanisms within the nucleus of the solitary tract in hypertension. Hypertension 55, 201-206 (2010).
43. Sheehan, D. V. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatr. 59, 22-23 (1998).
44. Colzato, L. S. & Hommel, B. Cannabis, cocaine, and visuomotor integration: Evidence for a role of dopamine D1 receptors in binding perception and action. Neuropsychologia 46, 1570-1575 (2008).
45. Colzato, L. S., Ruiz, M., van den Wildenberg, W. P. M. & Hommel, B. Khat use is associated with impaired working memory and cognitive flexibility. PLoS ONE 6, e20602 (2011).
46. Markus, C. R., Firk, C., Gerhardt, C., Kloek, J. & Smolders, G. J. F. Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacol. 201, 107-114 (2008).
47. Colzato, L. S., Jongkees, B. J., Sellaro, R., van den Wildenberg, W. & Hommel, B. Eating to stop: Tyrosine supplementation enhances inhibitory control but not response execution. Neuropsychologia 62, 398-402 (2014).
48. Colzato, L. S., Jongkees, B., Sellaro, R. & Hommel, B. Working memory reloaded: Tyrosine repletes updating in the N-Back task. Front. Behav. Neurosci. 7, 200 (2013). doi: 10.3389/fnbeh.2013.00200.
49. Abdou, A. M. et al. Relaxation and immunity enhancement effects of γ-aminobutyric acid (GABA) administration in humans. Biofactors 26, 201-208 (2006).
50. Yildiz, A., Wolf, O. T. & Beste, C. Stress intensifies demands on response selection during action cascading processes. Psychoneuroendocr. 42, 178-187 (2014).